WCG, a global provider of clinical research services, expanded its capabilities with the introduction of Statistical Consulting Solutions that aim to combat challenges involving resource constraints throughout the clinical research industry. The offering aims to revolutionize how organizations approach statistical analysis and decision-making.
 
WCG’s Statistical Consulting Solutions aim to provide comprehensive statistical support across all stages of trial design and regulatory strategy. From protocol reviews to final analyses, it covers an array of services including regulatory meeting support, study design assistance, clinical outcome assessment support, and more.
 
WCG’s statisticians serve as scientific partners, collaborating with researchers from various disciplines to develop interventions for disease prevention and treatment. With a focus on questioning data and exploring alternative explanations, WCG’s experts bring a unique perspective to statistical analysis that aims to help ensure robust and insightful outcomes for clients.
 
Statistical capabilities include clinical trial methodology, survival analysis, experimental design, longitudinal data analysis, meta-analysis, real-world evidence analyses. WCG also provides insight from its expertise in clinical outcome assessment and imaging studies. 

“Our Statistical Consulting Solutions represent a significant step forward in our commitment to empowering our clients with the tools and expertise needed to navigate the complex clinical research landscape,” remarked Sam Srivastava, chief executive officer, WCG. “By providing access to our team of seasoned statisticians, we aim to level the playing field, enabling our partners to compete more effectively in the market.”